Almost four years ago in my “Diabetes Update” newsletter I wrote about an ancient remedy that is being used again to treat stubborn wounds and ulcers. These ulcers are a major threat to anybody with diabetes who has neuropathy.
Diabetes Medication
The gliptins are coming to dinner. And to breakfast and lunch.
The gliptins are a promising new class of drugs that block the enzyme known by the catchy name dipeptidyl peptidase 4 or DPP-4. They include two drugs, vildagliptin (proposed trade name Galvus) from the Swiss pharamaceutical giant Novartis and sitagliptin phosphate (proposed trade name Januvia) from an American company, Merck.
If your blood glucose is under good control, it’s still better to check it after meals rather than before breakfast, as I wrote here recently. But new research presented at the American Diabetes Association’s 66th Scientific Sessions that I just attended in Washington indicates that it might make sense to check your blood glucose levels sooner after eating than we previously thought.
Byetta was the star of the show at the just concluded 66th Scientific Sessions of the American Diabetes Association in Washington. HealthCentral.com made it possible for me to attend this huge convention and report on it here.